Αρχική Uncategorized Διαφημιστείτε Uncategorized Διαφημιστείτε Από Ogkologos - 18 Ιανουαρίου, 2019 1316 0 Facebook Twitter Google+ Pinterest WhatsApp ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Enzalutamide Continues to Provide Substantial Long-Term OS Benefit at 8 Years for Patients with Metastatic Hormone-Sensitive Prostate Cancer Saving Time for Patients and Improving Well-Being Through Mindfulness and Fitness: Research from the 2023 ASCO Quality Care Symposium FDA Approves Encorafenib with Binimetinib for Metastatic Non-Small Cell Lung Cancer with a BRAF V600E Mutation MOST POPULAR ESMO Calls for Cancer to Be at the Core of the... 10 Ιουνίου, 2025 How We’re Working to Help People With Cancer Across the World 7 Απριλίου, 2021 Sacituzumab Govitecan Improves Outcomes Over Single-Agent Chemotherapy in Patients with Pretreated... 5 Μαρτίου, 2024 Reunión anual de la American Society of Clinical Oncology (ASCO) de... 3 Ιουνίου, 2022 Φόρτωση περισσοτέρων HOT NEWS Ahead of ESMO Immuno-Oncology Congress 2025: topics at a glance She Faced Breast Cancer At 16 With Little Help From Doctors.... “Glossy” Awareness Campaigns Weren’t Representing Her Cancer, So She Started #TrueCancerBodies FDA Grants Accelerated Approval to Adagrasib for KRAS G12C-Mutated NSCLC